John Vani, MD
Sports Medicine · Moberly, MONPI 1083727077
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Elite Orthopedics, LLC at 33.9% of the total. 2025 is the largest year on record at $1,799, 4.4 times the $412 reported in 2019.
Across 62 payments — averaging $71.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$2K
- Titan Surgical Group, LLC$1K
- Smith+Nephew$481
- Arthrex$268
- Johnson & Johnson$171
- Bayer$157
- plus $653 from 14 others
What the payments were for
- Travel & lodging$1,52234%
- Food & beverage$1,71039%
- Education$1,20027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 7 | $1,501 |
| Titan Surgical Group, LLC | 1 | $1,200 |
| Smith+Nephew | 7 | $481 |
| Arthrex | 2 | $268 |
| Johnson & Johnson(2 entities) | 9 | $171 |
| Bayer | 9 | $157 |
| Onkos Surgical, Inc. | 1 | $118 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $86 |
| Merck | 5 | $76 |
| Zimmer Biomet | 1 | $74 |
| United Therapeutics Corporation | 3 | $63 |
| AbbVie | 2 | $52 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $43 |
| AstraZeneca | 2 | $34 |
| Stryker | 2 | $27 |
| Bioventus LLC | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Conmed Corporation | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,432 in reported general payments places this provider in the 65th percentile of 127 sports medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 141 | $1,672 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $1,503 |
| Celecoxib | 18 | $437 |
| Diclofenac Sodium | 23 | $396 |
| Cephalexin | 14 | $109 |
| Tramadol Hcl | 18 | $106 |
| Methylprednisolone | 18 | $92 |
| Promethazine Hcl | 17 | $45 |
| Meloxicam | 24 | $38 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Moberly
- Kristin OliverColumbia$209K
- Steven DefrodaColumbia$101K
- Clayton NuelleColumbia$89K
- Justin DragerColumbia$78K
- Derrick KnapikSaint Louis$72K
- Shawn SahotaColumbia$69K
- James StannardColumbia$68K
- Joshua HamannColumbia$57K
- Jeffrey KlottColumbia$50K
- Scott KaarSt Louis$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.